The orthopedic devices market size in 2026 is experiencing steady transformation as healthcare providers increasingly adopt advanced solutions for managing musculoskeletal conditions, joint disorders, fractures, spinal complications, and sports-related injuries. Orthopedic devices include products used to support, repair, reconstruct, or stabilize bones and joints. Common orthopedic devices include rods, spacers, pins, cages, plates, and screws, which serve as anchors to improve and align fractured bones. Technological developments such as 3D printing, robotics, computer-assisted surgery, and artificial intelligence (AI) integration are also reshaping orthopedic procedures.
According to Fortune Business Insights, the global orthopedic devices market size was valued at USD 65.28 billion in 2025 and is projected to grow from USD 68.48 billion in 2026 to USD 105.45 billion by 2034, exhibiting a CAGR of 5.54% during the forecast period 2026-2034. North America dominated the orthopedic devices market with a market share of 54.92% in 2025. The market is being supported by the rising prevalence of osteoporosis and musculoskeletal diseases, increasing incidence of sports and traumatic injuries, technological advancements, and the growing elderly population. The growing number of surgical procedures involving orthopedic implants and instruments is also expected to support market expansion.
Orthopedic devices are designed to manage musculoskeletal complications affecting the bones and joints. These products are used across several orthopedic procedures, including joint reconstruction, spinal procedures, trauma treatment, arthroscopy, and orthobiologic applications. The increasing adoption of minimally invasive procedures has encouraged manufacturers to develop technologically advanced products that can support precision and improve surgical outcomes. Computer-assisted surgery, robotics, 3D printing, and AI-based treatment planning are among the technological developments influencing the orthopedic devices landscape. Customized products, including 3D-printed implants, are also being developed to address individual patient requirements.
The increasing incidence of musculoskeletal diseases and orthopedic injuries is a major factor supporting demand for orthopedic devices. These conditions can result in limited mobility and physical pain, increasing the need for orthopedic treatment and surgical procedures. The prevalence of osteoporosis is also contributing to demand for orthopedic surgical devices. Fortune Business Insights highlights the growing number of individuals affected by osteoporosis and low bone density as an important factor influencing the need for orthopedic care.
The expanding elderly population is another factor contributing to market growth. Older adults are more susceptible to hip fractures and other orthopedic injuries. The increasing number of hip fracture hospitalizations and falls among senior citizens is supporting demand for orthopedic procedures and devices.
Technological progress in orthopedics is supporting the development of advanced and minimally invasive devices. Robotics, computer-assisted surgery, 3D printing, and AI-based treatment planning are increasingly being incorporated into orthopedic procedures. These technologies are contributing to greater precision and supporting faster recovery and reduced hospital stays in minimally invasive procedures.
High procedure costs and postoperative complications can restrain market growth. Orthopedic surgical procedures may involve substantial costs, while potential complications include infections, dislocation, venous thrombosis, blood effusion, neuroparalysis, and limited range of motion. These factors can affect the adoption of orthopedic surgical procedures and devices.
The competitive landscape is characterized by diversified product portfolios, continuous product innovation, global distribution networks, and branding strategies. Regional and domestic players offering innovative orthopedic devices are contributing to increasing competition and pricing pressure within the market.
Consolidation strategies are also emerging among major industry participants. Companies are focusing on expanding their orthopedic portfolios and introducing technologically advanced products to address changing clinical requirements. Stryker, Zimmer Biomet, Smith & Nephew, and Johnson & Johnson Services, Inc. are identified among the prominent players, supported by their product portfolios and global presence.